A preclinical investigation into the potential associations of geraniin with ulcerative colitis alleviation through integrated multi-omics and in vivo analysis - Top-Institutions - MDSpire

A preclinical investigation into the potential associations of geraniin with ulcerative colitis alleviation through integrated multi-omics and in vivo analysis

  • By

  • Chang Cheng

  • Wei Wang

  • Tingting Zheng

  • Xiangmin Shi

  • Chong Fu

  • May 13, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Gastroenterology
    • GI Surgery

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Gastroenterology
    • GI Surgery

  • #3

    Study of a Prospective Adult Research Cohort (SPARC IBD)
    Study of a Prospective Adult Research Cohort (SPARC IBD)

    Not specified, Not specified

    Key Differentiators

    • Inflammatory Bowel Disease

  • #4

    Poznan University of Medical Sciences
    Poznan University of Medical Sciences

    Poznan, Poland

    Key Differentiators

    • Gastroenterology

  • #5

    University Hospital of the Princess
    University Hospital of the Princess

    Madrid, Spain

    Key Differentiators

    • Gastroenterology

Original Source(s)

A preclinical investigation into the potential associations of geraniin with ulcerative colitis alleviation through integrated multi-omics and in vivo analysis

  • by Chang Cheng, Wei Wang, Tingting Zheng, Xiangmin Shi, Chong Fu

  • May 13, 2026

Related Content

In silico design and experimental validation of a multi-epitope vaccine candidate against Helicobacter hepaticus associated chronic liver inflammation

Correction: Insights and Approaches for Immunometabolic Remodeling in Liver Transplantation

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.